Chemistry:TGFK-09SD

From HandWiki

TGFK-09SD, or TGFK09SD, is a serotonin 5-HT1A receptor agonist which is or was under development for the treatment of female sexual dysfunction but was never marketed.[1][2] It is taken orally.[1] The drug was developed by Fabre-Kramer Pharmaceuticals.[1] As of January 2016, it is in phase 2 clinical trials.[1] There have been no further updates on the development of the drug since then.[1] The chemical structure of TGFK-09SD does not yet appear to have been disclosed.[1]

See also

References

  1. ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "TGFK 09SD". 8 January 2016. https://adisinsight.springer.com/drugs/800032503. 
  2. ↑ "Details of the Drug-Related molecule(s) Interaction Atlas". 1 April 2024. https://drugmap.idrblab.net/data/drug-molecule-interaction/details/DMGWE4H. 

Template:Sexual dysfunction medications



Retrieved from "https://handwiki.org/wiki/index.php?title=Chemistry:TGFK-09SD&oldid=4246446"